These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 24359049)

  • 21. Effectiveness of fetal fibronectin testing compared with digital cervical assessment of women with preterm contractions.
    Mateus J; Pereira L; Baxter J; Berghella V; Tolosa J
    Am J Perinatol; 2007 Jun; 24(6):381-5. PubMed ID: 17566945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of rapid fetal fibronectin in predicting preterm delivery.
    Tekesin I; Marek S; Hellmeyer L; Reitz D; Schmidt S
    Obstet Gynecol; 2005 Feb; 105(2):280-4. PubMed ID: 15684152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetal fibronectin in patients at increased risk for premature birth.
    Vĕtr M; Kudela M; Prásilová J
    Acta Univ Palacki Olomuc Fac Med; 1996; 140():55-7. PubMed ID: 9431693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fetal fibronectin and preterm birth].
    Luo L; Lü Q; Wei F
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jan; 32(1):25-6. PubMed ID: 9596866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal fibronectin as predictor of successful induction of mid-trimester abortion.
    Mercorio F; Mercorio A; Votino C; Di Spiezio Sardo A; Barba GV; Nappi C
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):390-4. PubMed ID: 15762972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of fetal fibronectin testing in minimising hospital admissions, length of hospital stay and cost savings in women presenting with symptoms of pre-term labour.
    Dutta D; Norman JE
    J Obstet Gynaecol; 2010; 30(8):768-73. PubMed ID: 21126111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rational use of fetal fibronectin in the evaluation of premature labor risk].
    Rozenberg P; Nisand I; Malagrida L; Vayssière C; Goffinet F; Philippe HJ; Tribalat S; Giudicelli Y
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):288-93. PubMed ID: 8767228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervico-vaginal fetal fibronectin: predictive value during false labor.
    Langer B; Boudier E; Schlaeder G
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):218-21. PubMed ID: 9093134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fetal fibronectin: a method for detecting the presence of amniotic fluid.
    Eriksen NL; Parisi VM; Daoust S; Flamm B; Garite TJ; Cox SM
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):451-4. PubMed ID: 1495705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-8 and glucose in amniotic fluid, fetal fibronectin in vaginal secretions and preterm labor index based on clinical variables are optimal predictive markers for preterm delivery in patients with intact membranes.
    Yoneda S; Sakai M; Sasaki Y; Shiozaki A; Hidaka T; Saito S
    J Obstet Gynaecol Res; 2007 Feb; 33(1):38-44. PubMed ID: 17212664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Premature labor and fetal fibronectin in cervical and vaginal secretions].
    Lorenz-Eberhardt G; Weiss PA; Haas J; Pürstner P; Adelwöhrer NE
    Geburtshilfe Frauenheilkd; 1994 Jul; 54(7):414-6. PubMed ID: 7926575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Utility of the determination of the foetal fibronectina in pregnancies of 40 weeks or more to predict the beginning of labor].
    García González M; Rodríguez Ledesma R; Gutiérrez Castañeda M; Fernández Romero M; Casas Godoy A; Padilla García B
    Ginecol Obstet Mex; 2009 Feb; 77(2):89-95. PubMed ID: 19365950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancy outcome in women with preterm labor symptoms without cervical change.
    Rinehart BK; Terrone DA; Isler CM; Barrilleaux PS; Bufkin L; Morrison JC
    Am J Obstet Gynecol; 2001 Apr; 184(5):1004-7. PubMed ID: 11303212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Premature membrane rupture. Comparison of diagnostic tests].
    Trovò S; Brigato L; Plebani M; Brigato G; Grismondi GL
    Minerva Ginecol; 1998 Dec; 50(12):519-22. PubMed ID: 10069164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-Policy Implementation Review of Rapid Fetal Fibronectin (fFN) Testing for Preterm Labour in Alberta.
    Chuck AW; Thanh NX; Chari RS; Wilson RD; Janes-Kelley S; Wesenberg JC
    J Obstet Gynaecol Can; 2016 Jul; 38(7):659-666.e6. PubMed ID: 27591351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal fibronectin--how useful is it in the prediction of preterm birth?
    Leitich H; Kaider A
    BJOG; 2003 Apr; 110 Suppl 20():66-70. PubMed ID: 12763115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved management in threatened preterm labour with rapid fetal fibronectin testing.
    Parry E; Singh TG; Dow D; Noovao F
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):240-1. PubMed ID: 16704480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fetal fibronectin as a marker of prematurity in a high risk patient sample].
    Surbek D; Bösiger H; Pavic N; Huber P; Almendral AC; Holzgreve W
    Z Geburtshilfe Neonatol; 1997; 201(1):15-20. PubMed ID: 9172901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
    Incerti M; Ghidini A; Korker V; Pezzullo JC
    Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biophysical and biochemical screening for the risk of preterm labor.
    Wax JR; Cartin A; Pinette MG
    Clin Lab Med; 2010 Sep; 30(3):693-707. PubMed ID: 20638582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.